Ngā hua rapu - Lynda Chin

Whakamahine hua
  1. 1
    Genetics and genomics of melanoma

    Genetics and genomics of melanoma mā Papia Ghosh, Lynda Chin

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    HiCPlotter integrates genomic data with interaction matrices

    HiCPlotter integrates genomic data with interaction matrices mā Kadir C. Akdemir, Lynda Chin

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The INK4a/ARF locus and melanoma

    The INK4a/ARF locus and melanoma mā Norman E. Sharpless, Lynda Chin

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Translating insights from the cancer genome into clinical practice

    Translating insights from the cancer genome into clinical practice mā Lynda Chin, Joe W. Gray

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3–Mediated Oncogenesis

    Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3–Mediated Oncogenesis mā Kenneth L. Scott, Lynda Chin

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Malignant melanoma: modern black plague and genetic black box

    Malignant melanoma: modern black plague and genetic black box mā Lynda Chin, Glenn Merlino, Ronald A. DePinho

    I whakaputaina 1998
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Malignant melanoma: genetics and therapeutics in the genomic era

    Malignant melanoma: genetics and therapeutics in the genomic era mā Lynda Chin, Levi A. Garraway, David E. Fisher

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Making sense of cancer genomic data

    Making sense of cancer genomic data mā Lynda Chin, William C. Hahn, Gad Getz, Matthew Meyerson

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Emerging patterns of somatic mutations in cancer

    Emerging patterns of somatic mutations in cancer mā Ian R. Watson, Koichi Takahashi, P. Andrew Futreal, Lynda Chin

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Melanoma: from mutations to medicine

    Melanoma: from mutations to medicine mā Hensin Tsao, Lynda Chin, Levi A. Garraway, David E. Fisher

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Non-germline genetically engineered mouse models for translational cancer research

    Non-germline genetically engineered mouse models for translational cancer research mā Joerg Heyer, Lawrence N. Kwong, Scott W. Lowe, Lynda Chin

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair

    Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair mā Tony Gutschner, Monika Haemmerle, Giannicola Genovese, Giulio Draetta, Lynda Chin

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation

    Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation mā Roger A. Greenberg, Richard Allsopp, Lynda Chin, Gregg B. Morin, Ronald A. DePinho

    I whakaputaina 1998
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Reprogramming of a melanoma genome by nuclear transplantation

    Reprogramming of a melanoma genome by nuclear transplantation mā Konrad Hochedlinger, Robert Blelloch, Cameron Brennan, Yasuhiro Yamada, Minjung Kim, Lynda Chin, Rudolf Jaenisch

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model

    Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model mā Karuppiah Kannan, Norman E. Sharpless, Jin Xu, Rónán C. O’Hagan, Marcus Bosenberg, Lynda Chin

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence

    Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence mā Akitake Mukasa, Jill Wykosky, Keith L. Ligon, Lynda Chin, Webster K. Cavenee, Frank B. Furnari

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Role of the INK4a Locus in Tumor Suppression and Cell Mortality

    Role of the INK4a Locus in Tumor Suppression and Cell Mortality mā Manuel Serrano, Han‐Woong Lee, Lynda Chin, Carlos Cordón-Cardo, David Beach, Ronald A. DePinho

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Highly Recurrent <i>TERT</i> Promoter Mutations in Human Melanoma

    Highly Recurrent <i>TERT</i> Promoter Mutations in Human Melanoma mā Franklin W. Huang, Eran Hodis, Mary Jue Xu, Gregory V. Kryukov, Lynda Chin, Levi A. Garraway

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas

    Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas mā Nabeel Bardeesy, Boris C. Bastian, Aram F. Hezel, Dan Pinkel, Ronald A. DePinho, Lynda Chin

    I whakaputaina 2001
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Nuclear cloning of embryonal carcinoma cells

    Nuclear cloning of embryonal carcinoma cells mā Robert Blelloch, Konrad Hochedlinger, Yasuhiro Yamada, Cameron Brennan, Minjung Kim, Beatrice Mintz, Lynda Chin, Rudolf Jaenisch

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: